Idg-accel China Growth Fund Iii L.p. - Net Worth and Insider Trading

Idg-accel China Growth Fund Iii L.p. Net Worth

The estimated net worth of Idg-accel China Growth Fund Iii L.p. is at least $5 Million dollars as of 2024-11-13. Idg-accel China Growth Fund Iii L.p. is the 10% Owner of CASI Pharmaceuticals Inc and owns about 977,337 shares of CASI Pharmaceuticals Inc (CASI) stock worth over $5 Million. Details can be seen in Idg-accel China Growth Fund Iii L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Idg-accel China Growth Fund Iii L.p. has not made any transactions after 2018-03-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Idg-accel China Growth Fund Iii L.p.

To

Idg-accel China Growth Fund Iii L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Idg-accel China Growth Fund Iii L.p. owns 1 companies in total, including CASI Pharmaceuticals Inc (CASI) .

Click here to see the complete history of Idg-accel China Growth Fund Iii L.p.’s form 4 insider trades.

Insider Ownership Summary of Idg-accel China Growth Fund Iii L.p.

Ticker Comapny Transaction Date Type of Owner
CASI CASI Pharmaceuticals Inc 2018-03-21 10 percent owner

Idg-accel China Growth Fund Iii L.p. Latest Holdings Summary

Idg-accel China Growth Fund Iii L.p. currently owns a total of 1 stock. Idg-accel China Growth Fund Iii L.p. owns 977,337 shares of CASI Pharmaceuticals Inc (CASI) as of March 21, 2018, with a value of $5 Million.

Latest Holdings of Idg-accel China Growth Fund Iii L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CASI CASI Pharmaceuticals Inc 2018-03-21 977,337 5.60 5,473,087

Holding Weightings of Idg-accel China Growth Fund Iii L.p.


Idg-accel China Growth Fund Iii L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Idg-accel China Growth Fund Iii L.p. has made a total of 0 transactions in CASI Pharmaceuticals Inc (CASI) over the past 5 years. The most-recent trade in CASI Pharmaceuticals Inc is the acquisition of 308,642 shares on March 21, 2018, which cost Idg-accel China Growth Fund Iii L.p. around $10 Million.

Insider Trading History of Idg-accel China Growth Fund Iii L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Idg-accel China Growth Fund Iii L.p. Trading Performance

GuruFocus tracks the stock performance after each of Idg-accel China Growth Fund Iii L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Idg-accel China Growth Fund Iii L.p. is 11.75%. GuruFocus also compares Idg-accel China Growth Fund Iii L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Idg-accel China Growth Fund Iii L.p. within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Idg-accel China Growth Fund Iii L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Idg-accel China Growth Fund Iii L.p.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 34.2 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 34.68 LIMIT LIMIT LIMIT LIMIT LIMIT

Idg-accel China Growth Fund Iii L.p. Ownership Network

Ownership Network List of Idg-accel China Growth Fund Iii L.p.

No Data

Ownership Network Relation of Idg-accel China Growth Fund Iii L.p.

Insider Network Chart

Idg-accel China Growth Fund Iii L.p. Owned Company Details

What does CASI Pharmaceuticals Inc do?

Who are the key executives at CASI Pharmaceuticals Inc?

Idg-accel China Growth Fund Iii L.p. is the 10 percent owner of CASI Pharmaceuticals Inc. Other key executives at CASI Pharmaceuticals Inc include director & 10 percent owner & Chairman and CEO Wei-wu He , Chief Financial Officer Weihao Xu , and President Larry Zhang .

CASI Pharmaceuticals Inc (CASI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CASI Pharmaceuticals Inc (CASI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CASI Pharmaceuticals Inc (CASI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CASI Pharmaceuticals Inc (CASI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CASI Pharmaceuticals Inc Insider Transactions

No Available Data

Idg-accel China Growth Fund Iii L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Idg-accel China Growth Fund Iii L.p.. You might contact Idg-accel China Growth Fund Iii L.p. via mailing address: Unit 5505, 55th Floor, The Center, 99 Queen's Road K3 00000.